IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sanofi

Portfolio Profile

CIK: 0001121404 | Paris, I0

Investment Profile

Style

Deep Value

Turnover

Very Low

Orientation

Concentrated long-term
$629.9M
AUM
16
Positions
92.09%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1MeiraGTx Holdings plc(MGTX)12,197,737$134.2M21.30%
2Inhibrx Biosciences, Inc.(INBX)1,157,926$115.9M18.40%
3Novavax(NVAX)6,880,481$74.4M11.81%
4Korsana Biosciences(KRSA)1,994,011$63.8M10.13%
5Odyssey Therapeutics Inc.(ODTX)1,990,200$44.2M7.02%

Sector Allocation

Latest filing, equity positions only

Unclassified55.14% · $347.3M
Healthcare44.86% · $282.5M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare52.95%44.86%-8.09%
Unclassified47.05%55.14%+8.09%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$174.4M | 9 pos.
$165.9M | 9 pos.
$175.7M | 10 pos.
$260.4M | 9 pos.
$310.4M | 8 pos.
$336.0M | 9 pos.
6
AnaptysBio(ANAB)
821,917
$41.3M
6.56%
7Agomab Therapeutics NV(AGMB)2,783,096$30.9M4.90%
8First Tracks Biotherapeutics Inc.(TRAX)821,917$29.1M4.62%
9Electra Therapeutics Inc(ETRA)2,461,948$27.7M4.40%
10Attovia Therapeutics Inc(ATTO)1,082,855$18.6M2.95%
Cap SizePrev %Curr %Change
Unclassified47.05%55.14%+8.09%
Small Cap52.36%43.43%-8.93%
Micro Cap0.58%1.43%+0.85%
$534.0M | 10 pos.
$629.9M | 16 pos.
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26
Q3
26

Recent Activity

Quarter-over-quarter position changes

6
New
0
Closed
0
Increased
1
Decreased
9
Unchanged